Highest quality of Active Pharmaceutical Ingredients

Alfa is uniquely positioned in the global pharmaceutical market as an exclusive supplier of active pharmaceutical ingredients (APIs) and finished pharmaceutical & nutraceutical products.

The firm’s horizontal and vertical integration in selling and marketing capabilities enable our pharmaceutical partners and global healthcare markets to receive medicine more swiftly and catering to wider populations in need.

Alfa pharma and its partners provide the global pharmaceutical industry with the following reliable cGMP quality-value driven solutions:

  • Active pharmaceutical ingredients (APIs)
  • Finished products

Delivering the broader portfolio in the active pharmaceutical ingredients (API) industry.

Alfa’s partners supply high quality APIs to various markets worldwide. More than 100 quality APIs are manufactured at various state-of-the-art production facilities complying with all major industry standards. Alfa is wholly committed to environmental, health and safety (EHS) matters in all aspects of the business to ensure our supply chains are sustainable.

At Alfa, we take tremendous pride in our collaboration and we view our partners’ success as our own. Our comprehensive expertise and knowledge provides significant value to our partners. We devote all our resources to help them deliver high-quality generic and innovative products to the market rapidly and effectively. By continuously nurturing these partnerships through close working relationships, Alfa’s partners offer superior product quality and end-to-end support. This includes specialisedpersonnel assigned to each of our  customers, highly-responsivecustomer service representatives, logistical support, as well as R&D, QA, RA, IP and marketing personnel.

Our strong partnerships with suppliers enable timely introduction of new products to market, generating a steady flow of APIs.

Additionally, the experts from our partners RA and QA teams maintain the utmost global standards of quality and regulatory compliance, with unparallel IP support providing our customers with the freedom to operate efficiently, and providing them with a competitive edge.

Furthermore, from time to time, Alfa pharma proactively initiates unannounced product review with our suppliers. This ensures our partners to be prepared for frequent FDA, MHRA/TGA, and national MCH audits.

Providing for more than APIs, Alfa pharma is committed to our business partner success.

Contact us at info@alfapharma.eu
List of Active Pharmaceutical Ingredients (APIs)
# API Therapeutic Area Status
1 Allopurinol Antiurolithic CEP
2 Alogliptin Benzoate Antidiabetic Under development
3 Amantadine Hydrochloride Antiviral agent USP, JP, IP
4 Anastrozole Aromatase Inhibitor CEP
5 Antazoline Hydrochloride Ophthalmology DMF, small molecule
6 Antazoline Phosphate Ophthalmology DMF, small molecule
7 Antazoline Sulfate Ophthalmology DMF, small molecule
8 Apixaban Anticoagulant Under development
9 Apremilast Anti-arthritic/Anti-psori Under Development
10 Aprepitant Anti-emetic USDMF
11 Armodafinil Eugeroic USDMF
12 Azacytidine Myelodysplastic syndrom DMF, EDMF, CEP
13 Azelastine Hydrochloride Antihistaminic Under development
14 Baclofen Muscle relaxant USDMF
15 Bepotastine Besilate Antihistaminic Under development
16 Besifloxacin Hydrochloride Bacterial Conjunctivitis Under development
17 Betaxolol Hydrochloride Antiglaucoma CEP
18 Bisoprolol Fumarate Anti-hypertensive US-DMF, CEP, ASMF
19 Bleomycin Sulphate Anti-Cancer DMF, EDMF, CEP
20 Bortezomib Anti-Cancer DMF, EDMF, CEP
21 Brimonidine Tartrate Antiglaucoma CEP
22 Brinzolamide Antiglaucoma EU DMF
23 Bromfenac Sodium Antiinflammatory Under development
24 Glucagon Antidiabetes DMF, Peptide
25 Busulfan Antineoplastic CTD, Tech pack
26 Cabazitaxel Anti-Cancer DMF, EDMF, CEP
27 Gonadorelin Acetate Oncology CEP, DMF, Peptide
28 Camylofin dihydrochloride Anti-spasmodic 0
29 Canagliflozin Antidiabetic Under development
30 Canagliflozin Hemihydrate Anti-diabetic Under Development
31 Capecitabine Anti-Cancer DMF, EDMF, CEP
32 Atosiban Preproductive medicine DMF, Peptide
33 Carboplatin Anti-Cancer DMF, EDMF, CEP
34 Carfilzomib Multiple myeloma DMF, EDMF, CEP
35 Carmustine Antineoplastic CTD, Tech pack
36 Carvedilol Antihypertensive CEP, DMF
37 Celecoxib Anti-inflammatory CEP, DMF
38 Chlorzoxazone Muscle Relaxant CEP, DMF
39 Cinacalcet HCL Calcimimetic USDMF
40 Cisatracurium Neuromuscular DMF, EDMF, CEP
41 Cisplatin Anti-Cancer DMF, EDMF, CEP
42 Clobazam Anti-Convulsant USDMF
43 Cyclophosphamide Anti-Cancer DMF, EDMF, CEP
44 Dabigatran Etexilate Mesylate Anti-Coagulant USDMF
45 Dapagliflozin Antidiabetic Under development
46 Dapagliflozin (S)-Propanediol Mo Anti-diabetic Under Development
47 Daunorubicin Anti-Cancer DMF, EDMF, CEP
48 Deferasirox Iron Chelator USDMF
49 Goserelin Acetate Oncology CEP, DMF, Peptide
50 Desvenlafaxine Succinate  Monoh Anti-depressant Under Development
51 Dexlansoprazole Anti-ulcerant Under Development
52 Dextromethorphan Hydrobromi Antitussive USP, IP
53 Dicycloverine / Dicyclomine HCL Antispasmodic CEP, DMF
54 Diltiazem Hydrochloride Anti-hypertensive US-DMF, CEP, ASMF
55 dl-Cloprostenol Sodium Luteolytic agent USDMF
56 Docetaxel Anhydrous Anti-Cancer DMF, EDMF, CEP
57 Docetaxel Trihydrous Anti-Cancer DMF, EDMF, CEP
58 Domperidone Antiemetic CEP, DMF
59 Donepezil Hydrochloride Anti-alzheimer’s USDMF
60 Dorzolamide Hydrochloride Anti-Glaucoma CEP, DMF
61 Doxorubicin Anti-Cancer DMF, EDMF, CEP
62 Dronedarone Hydrochloride Anti-arrhythmic USDMF
63 Droxidopa Anti-parkinson Under Development
64 Empagliflozin Anti-diabetic Under Development
65 Ephedrine Hydrochloride Bronchodilator USP, IP
66 Epirubicin Anti-Cancer DMF, EDMF, CEP
67 Epothilone Anti-Cancer DMF, EDMF, CEP
68 Escitalopram Oxalate Anti-depressant CEP, DMF
69 Etoposide Anti-Cancer DMF, EDMF, CEP
70 Everolimus Anti-Cancer DMF, EDMF, CEP
71 L-cysteine Hydrochloride Monohydrate CEP, DMF, small molecule
72 Febuxostat Hyperuricemia Under development
73 Fludarabine Phosphate Anti-Cancer DMF, EDMF, CEP
74 Folic Acid Hematinic EU CEP
75 Fosaprepitant Dimeglumine Anti-emetic USDMF
76 Gliclazide Antidiabetic CEP
77 Glimepiride Antidiabetic CEP
78 L-Ornithine a-ketogultarate Monohydrate DMF, small molecule
79 Lanreotide Oncology DMF in progress
80 Leuprolide Acetate Oncology CEP, DMF, Peptide
81 Granisetron HCI Anti-Cancer DMF, EDMF, CEP
82 Imatinib Mesylate Tyrosine Kinase Inhibitor CEP, USDMF, CTD, Tech pack
83 Irbesartan Anti-hypertensive CEP, DMF
84 Irinotecan HCl Anti-Cancer DMF, EDMF, CEP
85 Iron Sucrose Iron deficiency DMF, EDMF, CEP
86 Ivabradine Anti-anginal Under Development
87 Ivacaftor Cystic Fibrosis Under Development
88 Ixabepilone Anti-Cancer DMF, EDMF, CEP
89 Ketoconazole Anti-fungal US-DMF, CEP, ASMF
90 Bivalurudin Cardiovascular diseases DMF, Peptide
91 Buserelin Oncology CEP, DMF, Peptide
92 Lacosamide Analgesic, Anticonvulsan EU DMF
93 Octreotide Acetate Oncology DMF, Peptide
94 Ledipasvir Hepatitis C CTD, Tech pack
95 Lenalidomide Thalidomide DMF, EDMF, CEP
96 Lercanidipine Anti-hypertensive 0
97 Letrozole Aromatase Inhibitor CEP, USDMF, CTD, Tech pack
98 Propofol Sedation CEP, DMF, small molecule
99 Levofloxacin Hemihydrate Fluoroquinolone USP, IP
100 Levofloxacin Hydrochloride Fluoroquinolone CP
101 Linagliptin Anti-diabetic Under Development
102 Losartan Potassium Anti-hypertensive CEP, DMF
103 Lurasidone Hydrochloride Anti-psychotic USDMF
104 Marbofloxacin Antibiotic EP
105 Mebeverine Hydrochloride Anti-spasmodic ASMF
106 Metformin DC Antidiabetic EU CEP
107 Metformin HCL Antidiabetic EU CEP
108 Mirabegron Urinary Incontinence Under development
109 Misoprostol Anti-ulcerant US-DMF, CEP, ASMF
110 Mitomycin C Anti-Cancer DMF, EDMF, CEP
111 Mitoxantrone HCI Anti-Cancer DMF, EDMF, CEP
112 Monosulfiram Ectoparasiticide 0
113 Moxifloxacin Hydrochloride Antibacterial Under development
114 Nedaplatin Anti-Cancer DMF, EDMF, CEP
115 Neostigmine Methylsulfate Anticholinesterase Under development
116 Somatostatin Others CEP, DMF, Peptide
117 Ofloxacin Fluoroquinolone USP, EP, JP, IP
118 Olopatadine Hydrochloride Antihistaminic EU DMF
119 Ondansetron HCL Antiemetic CEP, USDMF, CTD, Tech pack
120 Oxaliplatin Anti-Cancer DMF, EDMF, CEP
121 Paclitaxel Anti-Cancer DMF, EDMF, CEP
122 Paliperidone Anti-psychotic Under Development
123 Paliperidone Palmitate Anti-psychotic Under Development
124 Palonosetron HCL Antiemetic DMF, EDMF, CEP
125 Papaverine Hydrochloride Antipasmolytic USP, IP
126 Pemetrexed Disodium Anti-Cancer DMF, EDMF, CEP
127 Perindopril Tert-butylamine ACE Inhibitor US-DMF, CEP, ASMF
128 Pipotiazine Palmitate Antipsychotic DMF, EDMF, CEP
129 Pirarubicin Anti-Cancer DMF, EDMF, CEP
130 Pomalidomide Anti-Angiogenic USDMF, CTD, Tech pack
131 Posaconazole Antifungal Under development
132 Pramipexole Dihydrochloride M Anti-parkinson US-DMF, CEP, ASMF
133 Pregabalin Anticonvulsant CEP, DMF
134 Carbidopa Epilepsy & Parkinson’s CEP, DMF, small molecule
135 Pseudoephedrine Hydrochloride Decongestant USP, IP
136 Pseudoephedrine Sulfate Decongestant USP
137 Quetiapine Fumarate Antipsychotic CEP
138 Raloxifene Hydrochloride Anti-estrogen Under Development
139 Ranolazine Anti-anginal Under Development
140 Rasagiline Mesylate Antiparkinsonian Under development
141 Rasagiline Tartrate Antiparkinsonian Under development
142 Regadenoson Monohydrate Cardiovascular Under Development
143 Rivaroxaban Anti-Coagulant USDMF
144 Rizatriptan Benzoate Anti-Migraine CEP, USDMF, CTD, Tech pack
145 Rufinamide Anticonvulsant Under development
146 Salmeterol Xinafoate Antiasthmatic CEP, USDMF, CTD, Tech pack
147 Silymarin Liver diseases DMF, EDMF, CEP
148 Sitagliptin Antidiabetic Under development
149 Solifenacin succinate Antimuscarinic CEP, DMF
150 Teriparatide Acetate Osteoporosis DMF, Peptide
151 Sorafenib Tosylate Tyrosine Kinase Inhibitor USDMF, CTD
152 Spironolactone Diuretics CEP, ASMF
153 Sugammadex Sodium General anaesthesia Under Development
154 Telmisartan Anti-hypertensive CEP, DMF
155 Teriflonomide CNS Agent USDMF, CTD, Tech pack
156 Tetracosactide Oncology DMF, Peptide
157 Tetrabenazine Hyperkinetic Movement Under Development
158 Trimetazidine Dihydrochloride Cardiovascular diseases  CEP, small molecule
159 Thiotepa Antineoplastic CTD, Tech pack
160 Ticagrelor Anti-coagulant Under Development
161 Trazodone Hydrochloride Anti-depressant USDMF, ASMF
162 Trientine Dihydrochloride Chelating compound Under Development
163 Desmopressin Acetate Others CEP, DMF, Peptide
164 Etomidate Hypnotic DMF, Peptide
165 Exenatide Acetate Antidiabetes DMF, Peptide
166 Varenicline Tartrate Nicotinic antagonist Under Development
167 Verapamil Hydrochloride Anti-hypertensive US-DMF, CEP, ASMF
168 Vigabatrin Anti-convulsant Under Development
169 Vildagliptin Antidiabetic Under development
170 Vinorelbine Bitartrate Anti-Cancer DMF, EDMF, CEP
171 Vortioxetine Hydrobromide Anti-depressant Under Development
172 Zoledronic Acid Anti-Osteoporosis USDMF, CEP, CTD, Tech pack
173 Zolmitriptan Anti-Migraine USDMF, CTD, Tech pack